We are excited to announce that the bovine mastitis market is experiencing remarkable growth, boasting a robust Compound Annual Growth Rate (CAGR) of 5.3%. This expansion has propelled the market's value to an impressive milestone of US$ 2.1 billion. This upward trajectory reflects the increasing demand for innovative solutions in the prevention and management of bovine mastitis, a critical concern in the dairy industry. As key players continue to invest in advanced technologies and therapies, we anticipate sustained progress in tackling this significant challenge.
The report “Bovine Mastitis Market, By Type (Clinical, and Sub-Clinical), By Product (Antibiotics, and Others), By Route of Administration (Intramammary, and Systemic), By Therapy (Lactating Period and Dry Period (Antibiotics, and Others)) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Global Forecast till 2029”.
Sample link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4530
Key Highlights:
• In October 2018, Boehringer Ingelheim International GmbH introduced a new product for prevention of immunotherapy infections in dairy cattle the company introduced ‘Lockout,’ a blue colored non antibiotic internal teat sealant used for prevention of further intra-mammary infections in cattle.
• In August 2019, Elanco announced the agreement to acquire Bayer’s Animal Health Business, which will together provide both the companies a strong platform for the development of novel treatments for bovine mastitis.
• In February 2020, Merck & Co., Inc. announced the launch of shut out, and a new teat sealant product, for the treatment of bovine mastitis.
Analyst view:
From an analyst's perspective, the current dynamics within the bovine mastitis market are both encouraging and indicative of substantial potential. The steady 5.3% CAGR underscores the growing recognition of the economic and animal welfare impacts of bovine mastitis in the dairy sector. This upward trend is likely driven by increased adoption of effective diagnostic tools, novel treatment options, and preventative measures, all aimed at mitigating the toll of mastitis on milk production and herd health. As investments continue to pour into research and development, stakeholders can anticipate further advancements that will not only bolster market value but also contribute to more sustainable and efficient dairy operations.
Competitive Landscape:
The prominent player operating in the global market includes Zoetis, Merck & Co., Inc. (MSD Animal Health), Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
To know more
Contact Us:
Sales
Prophecy Market Insights
U.S. 1 860 531 2574
RoW: 917775049802
Email- [email protected]
Website- www.prophecymarketinsights.com
Blog- www.prophecyjournals.com